Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United Kingdom.

about

Bivalirudin versus heparin and provisional GP IIb/IIIa inhibitors in patients treated for ST-segment elevation myocardial infarctions: Comparison of outcomes in a "real-world" setting.

P2860

Q38736998-3DF52523-BECE-4656-8A12-9CB66304B785

P2860

Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United Kingdom.

Item

http://www.wikidata.org/entity/Q40191441

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Bivalirudin, glycoprotein inhi ...... vention in the United Kingdom.

@en

type

Item

label

Bivalirudin, glycoprotein inhi ...... vention in the United Kingdom.

@en

prefLabel

Bivalirudin, glycoprotein inhi ...... vention in the United Kingdom.

@en

P1476

Bivalirudin, glycoprotein inhi ...... rvention in the United Kingdom

@en

P2093

Alex Sirker

http://www.w3.org/2001/XMLSchema#string

David Hildick-Smith

http://www.w3.org/2001/XMLSchema#string

Derek Robinson

http://www.w3.org/2001/XMLSchema#string

Mark A de Belder

http://www.w3.org/2001/XMLSchema#string

Peter Ludman

http://www.w3.org/2001/XMLSchema#string

Rod Stables

http://www.w3.org/2001/XMLSchema#string

Tim Kinnaird

http://www.w3.org/2001/XMLSchema#string

P2860

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

Bivalirudin during primary PCI in acute myocardial infarction

Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.

Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.

Improved clinical outcomes with abciximab therapy in acute myocardial infarction: a systematic overview of randomized clinical trials.

Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding risk scores in STEMI undergoing primary PCI: insights from a cohort of 1391 patients.

Leukocyte count is a modulating factor for the mortality benefit of bivalirudin in ST-segment-elevation acute myocardial infarction: the HORIZONS-AMI trial.

Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial.

Reduction in cardiac mortality with bivalirudin in patients with and without major bleeding: The HORIZONS-AMI trial (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction).

Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes.

P304

1312-1320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHV631

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Simon Anderson

Mamas Mamas

P577

2015-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26685133

http://www.w3.org/2001/XMLSchema#string

Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United Kingdom.

about

P2860

P2860

Bivalirudin, glycoprotein inhibitor, and heparin use and association with outcomes of primary percutaneous coronary intervention in the United Kingdom.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698